Table: Mitsubishi Chemical HD -9-MTH group results (IFRS)
Feb 3 (Reuters)-
Mitsubishi Chemical Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 2.90 trln 2.36 trln 3.89 trln
(+23.1 pct) (-13.7 pct) (+19.3 pct)
Operating 218.24 728 mln 344.00
(-99.5 pct) (+623.9 pct)
Pretax 208.18 loss 12.77 328.00
(+896.7 pct)
Net 122.13 loss 47.83 192.00
EPS Basic 85.95 yen loss 33.68 yen 135.12 yen
EPS Diluted 79.06 yen loss 33.68 yen
Ann Div 24.00 yen 30.00 yen
-Q2 Div 15.00 yen 12.00 yen
-Q4 Div 12.00 yen 15.00 yen
NOTE - Mitsubishi Chemical Holdings Corp.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)